ESCCA 2016 will start on Sunday morning 11 September and will end on Wednesday afternoon 14 September at 17.30 hrs.
The final programme is now available! It includes the oral abstract presentations. It can be downloaded here:
The programme at a glance can be downloaded on this page.
The poster overview can be downloaded here.
The ESCCA 2016 Conference is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. For more information, please see the Accreditation page.
On Sunday and Monday morning, 3 concurrent education programmes are scheduled. Pre-registration via the online registration form for 1 education programme is compulsory. .
A - Advanced Hemato-Oncology
The latest knowledge in the fields of acute leukemia, chronic lymphoproliferative disorders, plasma cell malignancies, chronic myeloid malignancies and myeloproliferative neoplasms, mydelodysplastic syndromes, red cell disorders and PNH will be provided by 12 internationally renowned hematopathologists. Speakers will each offer a 35 minute lecture detailing the key advances in their field of hemato-oncology that impact clinical cytometry.These sessions are suitable for experienced cytometrists with a good level of background knowledge.
B - Clinical Diagnostic Cytometry - this education programme is fully booked
The key clinical, scientific and technical issues in diagnostic cytometry will be reviewed by speakers with a focus on the practical approaches used in different expert centres. The programme will combine lectures with more interactive approaches including data analysis, Q&A and quizzes. These sessions are directed towards scientists and technicians wishing to gain a greater knowledge of the role of cytometry in diagnostics. Maximum number of participants is 80, divided over 2 groups (the same programme will be run twice in parallel sessions; teachers will rotate).
C - Advanced Immunology
An advanced approach to the immunophenotypic and functional characterization of innate and adaptive immune cells will be illustrated by internationally recognised scientists working on macrophages and dendritic cells, innate lymphoid cells, NK cells, B and T lymphocytes. These sessions are directed towards advanced cytometrists with a good level of immunological background, who wish to update and expand their competencies in translational and experimental Immunology.
Meet the Expert sessions
During the breaks on Monday, Tuesday and Wednesday you have the opportunity to meet an expert during the Meet The Expert sessions taking place in the Exhibition hall during the lunch breaks. A unique opportunity to ask questions, opinion, advice directly to the expert! An overview of the topics and the experts can be downloaded here. Free access, limited places, first come first served.
Selected Best Poster Abstract Presentations
This plenary session is scheduled on Sunday 11 September from 18.00-18.50 hrs. It comprises brief oral presentations selected from abstracts accepted for posters but receiving a high ranking from the abstract reviewer committee. This includes a mix of late-breaking submissions from experienced authors alongside novel submissions from less experienced cytometrists.
Best Oral Abstract Presentations & Best Poster Presentations
The 3 best oral abstracts will be selected for presentation in the Best Oral Presentations session on Wednesday morning. One of the presenters will be selected for the ESCCA Best Oral Award.
The best poster will be selected by the delegates on-site.
The winners will be announced in the ESCCA Award Session on Wednesday afternoon and will be awarded with to a free registration for the 2017 Conference.
Joint sessions UK NEQAS
On Wednesday afternoon UK NEQAS for Leucocyte Immunophenotyping is hosting some joint sessions. All ESCCA Conference delegates are welcome to attend as the content is informative for all clinical cytometrists!
Session highlights include: 'The Future of Minimal Residual Disease Testing in Leukaemia', 'Disease monitoring using cellular or molecular methods', 'Update on UK NEQAS Leucocyte Immunophenotyping MRD programmes','UK NEQAS Leucocyte Immunophenotyping Focus Session', 'UK NEQAS Leucocyte Immunophenotyping program developments, and ‘Liam's Laboratory Nightmares.
UK NEQAS for Leucocyte Immunophenotyping participants wishing to attend can register through the dedicated link they have received by email from UK NEQAS.
Joint sessions Scottish Society of Cytomics
On Wednesday morning the Scottish Society of Cytomics and ESSCA are jointly hosting sessions on Regenerative Medicine and Apoptosis from Bench to Bedside.